3D Models for Ovarian Cancer
Author:
Kast Verena,Loessner Daniela
Publisher
Springer International Publishing
Reference40 articles.
1. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7–33. 2. Bowtell, D. D., Bohm, S., Ahmed, A. A., Aspuria, P. J., Bast, R. C., Jr., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., Brenton, J. D., Chiappinelli, K. B., Martins, F. C., Coukos, G., Drapkin, R., Edmondson, R., Fotopoulou, C., Gabra, H., Galon, J., Gourley, C., Heong, V., Huntsman, D. G., Iwanicki, M., Karlan, B. Y., Kaye, A., Lengyel, E., Levine, D. A., Lu, K. H., McNeish, I. A., Menon, U., Narod, S. A., Nelson, B. H., Nephew, K. P., Pharoah, P., Powell, D. J., Jr., Ramos, P., Romero, I. L., Scott, C. L., Sood, A. K., Stronach, E. A., & Balkwill, F. R. (2015). Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer. Nature Reviews. Cancer, 15(11), 668–679. 3. Patch, A. M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., Kassahn, K. S., Newell, F., Quinn, M. C., Kazakoff, S., Quek, K., Wilhelm-Benartzi, C., Curry, E., Leong, H. S., Australian Ovarian Cancer Study Group, Hamilton, A., Mileshkin, L., Au-Yeung, G., Kennedy, C., Hung, J., Chiew, Y. E., Harnett, P., Friedlander, M., Quinn, M., Pyman, J., Cordner, S., O’Brien, P., Leditschke, J., Young, G., Strachan, K., Waring, P., Azar, W., Mitchell, C., Traficante, N., Hendley, J., Thorne, H., Shackleton, M., Miller, D. K., Arnau, G. M., Tothill, R. W., Holloway, T. P., Semple, T., Harliwong, I., Nourse, C., Nourbakhsh, E., Manning, S., Idrisoglu, S., Bruxner, T. J., Christ, A. N., Poudel, B., Holmes, O., Anderson, M., Leonard, C., Lonie, A., Hall, N., Wood, S., Taylor, D. F., Xu, Q., Fink, J. L., Waddell, N., Drapkin, R., Stronach, E., Gabra, H., Brown, R., Jewell, A., Nagaraj, S. H., Markham, E., Wilson, P. J., Ellul, J., McNally, O., Doyle, M. A., Vedururu, R., Stewart, C., Lengyel, E., Pearson, J. V., Waddell, N., de Fazio, A., Grimmond, S. M., & Bowtell, D. D. (2015). Whole-genome characterization of chemoresistant ovarian cancer. Nature, 521(7553), 489–494. 4. Lengyel, E., Burdette, J. E., Kenny, H. A., Matei, D., Pilrose, J., Haluska, P., Nephew, K. P., Hales, D. B., & Stack, M. S. (2014). Epithelial ovarian cancer experimental models. Oncogene, 33(28), 3619–3633. 5. Kenny, H. A., Lal-Nag, M., Shen, M., Kara, B., Nahotko, D. A., Wroblewski, K., Fazal, S., Chen, S., Chiang, C. Y., Chen, Y. J., Brimacombe, K. R., Marugan, J., Ferrer, M., & Lengyel, E. (2020). Quantitative high-throughput screening using an organotypic model identifies compounds that inhibit ovarian cancer metastasis. Molecular Cancer Therapeutics, 19(1), 52–62.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|